These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 30863058

  • 1. D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming.
    Tan X, Fang Y, Ren Y, Li Y, Wu P, Yang X, Liu W.
    Int J Nanomedicine; 2019; 14():1255-1268. PubMed ID: 30863058
    [Abstract] [Full Text] [Related]

  • 2. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T, Chen D, Liu K, Qi Y, Tian Y, Sun P, Liu Y, Li Z.
    ACS Appl Mater Interfaces; 2015 Aug 19; 7(32):18064-75. PubMed ID: 26214761
    [Abstract] [Full Text] [Related]

  • 3. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
    Yu P, Yu H, Guo C, Cui Z, Chen X, Yin Q, Zhang P, Yang X, Cui H, Li Y.
    Acta Biomater; 2015 Mar 19; 14():115-24. PubMed ID: 25498306
    [Abstract] [Full Text] [Related]

  • 4. Synergistic effects of antitumor efficacy via mixed nano-size micelles of multifunctional Bletilla striata polysaccharide-based copolymer and D-α-tocopheryl polyethylene glycol succinate.
    Liu Y, Wu J, Huang L, Qiao J, Wang N, Yu D, Zhang G, Yu S, Guan Q.
    Int J Biol Macromol; 2020 Jul 01; 154():499-510. PubMed ID: 32194114
    [Abstract] [Full Text] [Related]

  • 5. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
    Metin E, Mutlu P, Gündüz U.
    Anticancer Agents Med Chem; 2018 Jul 01; 18(8):1138-1147. PubMed ID: 29532763
    [Abstract] [Full Text] [Related]

  • 6. Enhanced anticancer effect of doxorubicin by TPGS-coated liposomes with Bcl-2 siRNA-corona for dual suppression of drug resistance.
    Li Y, Tan X, Liu X, Liu L, Fang Y, Rao R, Ren Y, Yang X, Liu W.
    Asian J Pharm Sci; 2020 Sep 01; 15(5):646-660. PubMed ID: 33193866
    [Abstract] [Full Text] [Related]

  • 7. Mixed micelles for encapsulation of doxorubicin with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines versus Doxil®.
    Cagel M, Bernabeu E, Gonzalez L, Lagomarsino E, Zubillaga M, Moretton MA, Chiappetta DA.
    Biomed Pharmacother; 2017 Nov 01; 95():894-903. PubMed ID: 28903185
    [Abstract] [Full Text] [Related]

  • 8. α-Tocopherol Polyethylene Glycol 1000 Succinate-Based Cationic Liposome for the Intracellular Delivery of Doxorubicin in MDA-MB-231 Triple-Negative Breast Cancer Cell Line.
    Sandal P, Patel P, Singh D, Gupta GD, Kurmi BD.
    Assay Drug Dev Technol; 2023 Nov 01; 21(8):345-356. PubMed ID: 38010987
    [No Abstract] [Full Text] [Related]

  • 9. Synergistic effect of pH-responsive folate-functionalized poloxamer 407-TPGS-mixed micelles on targeted delivery of anticancer drugs.
    Butt AM, Mohd Amin MC, Katas H.
    Int J Nanomedicine; 2015 Nov 01; 10():1321-34. PubMed ID: 25709451
    [Abstract] [Full Text] [Related]

  • 10. Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice.
    Murugesan K, Srinivasan P, Mahadeva R, Gupta CM, Haq W.
    Int J Nanomedicine; 2020 Nov 01; 15():10547-10559. PubMed ID: 33414637
    [Abstract] [Full Text] [Related]

  • 11. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
    Zhang J, Tao W, Chen Y, Chang D, Wang T, Zhang X, Mei L, Zeng X, Huang L.
    J Mater Sci Mater Med; 2015 Apr 01; 26(4):165. PubMed ID: 25791459
    [Abstract] [Full Text] [Related]

  • 12. Vitamin E-based micelles enhance the anticancer activity of doxorubicin.
    Danhier F, Kouhé TT, Duhem N, Ucakar B, Staub A, Draoui N, Feron O, Préat V.
    Int J Pharm; 2014 Dec 10; 476(1-2):9-15. PubMed ID: 25245548
    [Abstract] [Full Text] [Related]

  • 13. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
    Xiong S, Wang Z, Liu J, Deng X, Xiong R, Cao X, Xie Z, Lei X, Chen Y, Tang G.
    Colloids Surf B Biointerfaces; 2019 Jan 01; 173():346-355. PubMed ID: 30316081
    [Abstract] [Full Text] [Related]

  • 14. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
    Xie Q, Deng W, Yuan X, Wang H, Ma Z, Wu B, Zhang X.
    Eur J Pharm Biopharm; 2018 Jan 01; 122():87-95. PubMed ID: 29032193
    [Abstract] [Full Text] [Related]

  • 15. Host-guest supramolecular hydrogel based on nanoparticles: co-delivery of DOX and siBcl-2 for synergistic cancer therapy.
    Peng D, Gao H, Huang P, Shi X, Zhou J, Zhang J, Dong A, Tang H, Wang W, Deng L.
    J Biomater Sci Polym Ed; 2019 Jul 01; 30(10):877-893. PubMed ID: 31025910
    [Abstract] [Full Text] [Related]

  • 16. The cancer targeting potential of D-α-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubes.
    Mehra NK, Verma AK, Mishra PR, Jain NK.
    Biomaterials; 2014 May 01; 35(15):4573-88. PubMed ID: 24612818
    [Abstract] [Full Text] [Related]

  • 17. Codelivery of doxorubicin and elacridar to target both liver cancer cells and stem cells by polylactide-co-glycolide/d-alpha-tocopherol polyethylene glycol 1000 succinate nanoparticles.
    Chen D, Pan X, Xie F, Lu Y, Zou H, Yin C, Zhang Y, Gao J.
    Int J Nanomedicine; 2018 May 01; 13():6855-6870. PubMed ID: 30498347
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
    Bao Y, Yin M, Hu X, Zhuang X, Sun Y, Guo Y, Tan S, Zhang Z.
    J Control Release; 2016 Aug 10; 235():182-194. PubMed ID: 27264552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.